Atypical Imaging Features of Epstein-Barr Virus–Positive Primary Central Nervous System Lymphomas in Patients without AIDS

REFERENCES

1. 1.↵
   1. Rouah E,
   2. Rogers BB,
   3. Wilson DR,
   4. et al

   . Demonstration of Epstein-Barr virus in primary central nervous system lymphomas by the polymerase chain reaction and in situ hybridization. Hum Pathol 1990;21:545–50

   CrossRefPubMed
2. 2.↵
   1. List AF,
   2. Greer JP,
   3. Cousar JP,
   4. et al

   . Primary brain lymphomas in the immunocompetent host: relation to Epstein-Barr virus. Mod Pathol 1990;3:609–12

   PubMed
3. 3.↵
   1. Kleinschmidt-DeMasters BK,
   2. Damek DM,
   3. Lillehei KO,
   4. et al

   . Epstein Barr virus-associated primary CNS lymphomas in elderly patients on immunosuppressive medications. J Neuropathol Exp Neurol 2008;67:1103–11

   CrossRefPubMed
4. 4.↵
   1. Oyama T,
   2. Ichimura K,
   3. Suzuki R,
   4. et al

   . Senile EBV+ B-cell lymphoproliferative disorders: A clinicopathologic study of 22 patients. Am J Surg Pathol 2003;27:16–26

   CrossRefPubMedWeb of Science
5. 5.↵
   1. Swerdlow SH,
   2. Campo E,
   3. Harris NL,
   4. et al.

   1. Nakamura S,
   2. Jaffe ES,
   3. Swerdlow SH

   . EBV positive diffuse large B- cell lymphoma of the elderly. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARS Press; 2008:243–44
6. 6.↵
   1. Shimoyama Y,
   2. Asano N,
   3. Kojima M,
   4. et al

   . Age-related EBV-associated B-cell lymphoproliferative disorders: diagnostic approach to a newly recognized clinicopathological entity. Pathol Int 2009;59:835–43

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Oyama T,
   2. Yamamoto K,
   3. Asano N,
   4. et al

   . Age-related EBV associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients. Clin Cancer Res 2007;13:5124–32

   Abstract/FREE Full Text
8. 8.↵
   1. Asano N,
   2. Yamamoto K,
   3. Tamaru JI,
   4. et al

   . Age-related EBV associated B-cell lymphoproliferative disorders: comparison with EBV-positive classical Hodgkin lymphoma in elderly patients. Blood 2009;113:2629–36

   Abstract/FREE Full Text
9. 9.↵
   1. Park S,
   2. Lee J,
   3. Ko YH,
   4. et al

   . The impact of the Epstein-Barr virus status on clinical outcome in diffuse large B cell lymphoma. Blood 2007;110:972–78

   Abstract/FREE Full Text
10. 10.↵
    1. Emblem KE,
    2. Nedregaard B,
    3. Nome T,
    4. et al

    . Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008;247:808–17

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Law M,
    2. Young R,
    3. Babb J,
    4. et al

    . Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007;28:761–66

    Abstract/FREE Full Text
12. 12.↵
    1. Thurnher MM,
    2. Rieger A,
    3. Kleibl-Popov C,
    4. et al

    . Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings. Neuroradiology 2001;43:29–35

    CrossRefPubMed
13. 13.↵
    1. Haldorsen IS,
    2. Kråkenes J,
    3. Krossnes BK,
    4. et al

    . CT and MR imaging features of primary central nervous system lymphoma in Norway, 1989–2003. AJNR Am J Neuroradiol 2009;30:744–51

    Abstract/FREE Full Text
14. 14.↵
    1. Guo AC,
    2. Cummings DJ,
    3. Dash RC,
    4. et al

    . Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224:177–83

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Toh CH,
    2. Castillo M,
    3. Wong AM-C,
    4. et al

    . Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29:471–75

    Abstract/FREE Full Text
16. 16.↵
    1. Krabbe K,
    2. Gideon P,
    3. Wagn P,
    4. et al

    . MR diffusion imaging of human intracranial tumours. Neuroradiology 1997;39:483–89

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Calli C,
    2. Kitis O,
    3. Yunten N,
    4. et al

    . Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58:394–403

    CrossRefPubMed
18. 18.↵
    1. Sugita Y,
    2. Terasaki M,
    3. Niino D,
    4. et al

    . Epstein-Barr virus- associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing. J Neurooncol 2010;100:271–79

    CrossRefPubMed
19. 19.↵
    1. Barajas RF Jr..,
    2. Rubenstein JL,
    3. Chang JS,
    4. et al

    . Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. AJNR Am J Neuroradiol 2010;31:60–66

    Abstract/FREE Full Text
20. 20.↵
    1. Wieduwilt MJ,
    2. Valles F,
    3. Issa S,
    4. et al

    . Immunochemotherapy with intensive consolidation for primary central nervous system lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. Clin Cancer Res 2012;18:1146–55

    Abstract/FREE Full Text